U.S. Markets open in 18 hrs, 2 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 8.68 11:35 AM EST | |
|---|---|---|
| Day High | 9.04 03:27 PM EST |
|
| Range | 0.36 |
| Volume | 362,129 | |
|---|---|---|
| 30-Day Avg Vol | 856,000 |
|
| Difference | -57.70% |
| Market Cap | 408.19 M | |
|---|---|---|
| Mkt Cap Chg | 9.54 M |
| Shares Out | 45.45 M | |
|---|---|---|
| % Shrs Traded | 0.80% | |
| 1yr EPS Est | -0.257 |
| 52-Wk Low | 2.95 | |
|---|---|---|
| 52-Wk High | 9.32 |
|
| Range | 6.37 |
| Prev Close | 8.77 11/5/09 | |
|---|---|---|
| Today's Open | 8.69 | |
| Change | -0.91% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 10.57 M |
| Revenue (LFY) | 196.93 M | |
|---|---|---|
| Earnings (LFY) | -2.72 M | |
| Earnings (MRQ) | 133,000.00 | |
| Next Earn Est | -0.072 | |
| Next Earnings | 02/15/2010 |
|
| EPS (TTM) | 0.02 | |
| 1yr EPS Growth | -221.25% |
| P/E Ratio (TTM) | 449.00 | |
|---|---|---|
| P/E Ratio (Fwd) | -34.00 | |
| PEG Ratio | — | |
| Return on Equity | -2.32 | |
| Beta | 1.25 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
Enzon Pharmaceuticals has deadly diseases PEGged. The firm's proprietary PEGylation process enhances existing pharmaceutical treatments by attaching a customized molecule to the pharmaceutical; the attachment ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.072 2/15/10 | — — |
—
—
|
| Last Quarter | -0.096 9/30/09 | 0.00 9/30/09 |
0.096
Beat
|
| 2 Quarters Ago | -0.015 6/30/09 | -0.11 6/30/09 |
-0.095
Missed
|
| Quarterly - 09/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 30.94 M | 196.94 M |
| Gross Profit | 15.00 M | 134.57 M |
| Operating Income | -12.26 M | 5.17 M |
| Net Income | 133,000.00 | -2.72 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts